Alexandre Weinstein Manieu - 29 Oct 2025 Form 4 Insider Report for Pluri Inc. (PLUR)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
20 Nov 2025, 11:35:50 UTC
Prior SEC filing
01 Jul 2025
Next SEC filing
08 Dec 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Alexandre Weinstein Manieu

Key filing fact

Alexandre Weinstein Manieu filed Form 4 for Pluri Inc. (PLUR) on 20 Nov 2025.

Key facts

  • This page summarizes Alexandre Weinstein Manieu's Form 4 filing for Pluri Inc. (PLUR).
  • 5 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 20 Nov 2025, 11:35.

Change

  • Previous filing in this sequence was filed on 01 Jul 2025.
  • Current net transaction value: +$2,087,056.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (2)

CIK 0001833124 Primary reporting owner

Manieu Alexandre Weinstein

Relationship
Director, 10%+ Owner
Address
APT 8002, BURGENSTOCK HOTELS & RESORT,, BURGENSTOCK 30, OBBURGEN, SWITZERLAND
Signature
/s/ Alexandre Weinstein Manieu
Signature date
20 Nov 2025
CIK 0002055515

Chutzpah Holdings Ltd

Relationship
Director, 10%+ Owner
Address
4TH FLOOR, LIBERATION HOUSE, CASTLE STREET, ST. HELIER, JERSEY
Signature
/s/ Ana Ventura Authorized Officer For Beaumont (Directors) Limited Sole Corporate Director
Signature date
20 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PLUR transaction

Common Stock

Award

Transaction value
$0
Shares
+10,250
Change %
Price
$0.000000
Shares after
10,250
Date
25 Feb 2025
Ownership
Direct
PLUR transaction

Common Stock

Options Exercise

Transaction value
$100
Shares
+1,002,169
Change %
+108%
Price
$0.000100
Shares after
1,933,415
Date
29 Oct 2025
Ownership
Shares indirectly held through Chutzpah Holdings Limited
Footnotes
F1, F3
PLUR transaction

Common Stock

Purchase

Transaction value
$2,086,956
Shares
+452,702
Change %
Price
$4.61
Shares after
452,702
Date
28 Apr 2025
Ownership
Shares indirectly held through Plantae Bioscience Ltd.
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PLUR transaction Derivative

Pre-Funded Warrants to purchase Common Shares

Options Exercise

Transaction value
$0
Shares
-1,002,169
Change %
-92%
Price
$0.000000
Shares after
84,599
Date
29 Oct 2025
Ownership
Indirectly held through Chutzpah Holdings Limited
Underlying class
Common Shares
Underlying amount
0
Exercise price
$0.000100
Footnotes
F1, F3, F4, F5, F7
PLUR transaction Derivative

Common Warrants

Award

Transaction value
$0
Shares
+84,599
Change %
Price
$0.000000
Shares after
84,599
Date
23 Jan 2025
Ownership
Indirectly held through Chutzpah Holdings Limited
Underlying class
Common Shares
Underlying amount
0
Exercise price
$5.57
Footnotes
F1, F4, F6, F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

This statement is jointly filed by and on behalf of each of Chutzpah Holdings Limited ("Chutzpah") and Mr. Weinstein. Mr. Weinstein indirectly owns 100% of Chutzpah and may be deemed to beneficially own securities owned by Chutzpah.

Footnote F2

Mr. Weinstein indirectly owns 77% of Plantae Bioscience Ltd. ("Plantae") and may be deemed to beneficially own securities owned by Plantae. Neither the filing of this statement nor anything herein shall be deemed an admission that Mr. Weinstein is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the beneficial owner of any securities owned by Plantae. Mr. Weinstein disclaims beneficial ownership of such securities covered by this statement, except to the extent of his pecuniary interest in such securities. Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or13(g) of the Act or any other purpose, a member of a group with respect to the issuer or securities of the issuer.

Footnote F3

In connection with the issuance of common shares in a private placement transaction to Chutzpah on January 23, 2025 (previously reported by the reporting person on Form 3 filed with the Securities and Exchange Commission on February 18, 2025), the reporting person also received 26,030 prefunded warrants to purchase common shares, which, together with the 976,139 prefunded warrants to purchase common shares issued on April 25, 2025 under an amendment to its previously executed Securities Purchase Agreement, entered into on January 23, 2025 by the Company and Chutzpah, became exercisable following the Company's shareholders meeting on June 30, 2025. The total number of pre-funded warrants being reported after being exercised by the reporting person is 1,002,169 consisting of 976,139 plus 26,030 pre-funded warrants.

Footnote F4

On January 23, 2025, Pluri Inc. ("Pluri") entered into a Securities Purchase Agreement with Chutzpah, relating to a private placement offering of: (i) 1,383,948 common shares, par value $0.00001 per share of Pluri, (ii) pre-funded warrants to purchase up to 26,030 Common Shares, and (iii) common warrants to purchase up to 84,599 common shares. The reporting person had previously omitted filing a transaction that occurred on January 1, 2025, which was inadvertently omitted from a prior Form 4. The reporting person became aware of the omission on October 31,2025 and is reporting the transaction promptly after such discovery.

Footnote F5

1,002,169 pre-funded warrants are being exercised.

Footnote F6

The common warrants are exercisable until June 30, 2028.

Footnote F7

Pre-Funded Warrants were acquired in exchange for common shares. Common Warrants were issued as part of the January 23, 2025 transaction for no additional consideration.

SEC remarks

Exhibit Index: Exhibit 99.1 - Joint Filer Information (incorporated by reference to Exhibit 99.1 for Form 3 filed with the Securities and Exchange Commission on February 18, 2025). Exhibit 99.2 - Joint Filing Agreement (incorporated by reference to Exhibit 99.2 for Form 3 filed with the Securities and Exchange Commission on February 18, 2025). Each reporting person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the beneficial owner of any securities covered by this statement. Each reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities. Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or13(g) of the Act or any other purpose, a member of a group with respect to the issuer or securities of the issuer.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .